martes, 13 de agosto de 2024
FDA rejects MDMA as psychedelic-based treatment for mental health, PTSD The agency has requested that Lykos Therapeutics conduct another Phase 3 trial to confirm safety and efficacy Melissa Rudy By Melissa Rudy Fox News Published August 10, 2024 12:30pm EDT
FDA rejects MDMA as psychedelic-based treatment for mental health, PTSD
The agency has requested that Lykos Therapeutics conduct another Phase 3 trial to confirm safety and efficacy
Melissa Rudy By Melissa Rudy Fox News
Published August 10, 2024 12:30pm EDT
https://www.foxnews.com/health/fda-rejects-mdma-psychedelic-based-treatment-mental-health-ptsd
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario